Aspen notes results of Covid-19 trial using a drug it has rights to
The drug maker has rights to dexamethasone, with preliminary results of a trial in the UK showing it can be life-saving for some Covid-19 patients
17 June 2020 - 11:26
Drug maker Aspen Pharmacare said on Wednesday it had noted media reports regarding a Covid-19 trial using dexamethasone, a drug it has rights to.
The World Health Organisation (WHO) said on Tuesday a trial had shown that dexamethasone, a corticosteroid, could be life-saving for patients who were critically ill with Covid-19. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.